Suppr超能文献

维生素 D 依赖性佝偻病 1B 型(25-羟化酶缺乏症):一种罕见疾病还是一种被误诊的疾病?

Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?

机构信息

CHU de Caen, Department of Genetics, Molecular Genetics Laboratory and Reference Center for Rare Diseases of Calcium and Phosphorus Metabolism, Caen, France.

Université Caen Normandie, Medical School, Caen, France.

出版信息

J Bone Miner Res. 2017 Sep;32(9):1893-1899. doi: 10.1002/jbmr.3181. Epub 2017 Jul 13.

Abstract

Vitamin D requires a two-step activation by hydroxylation: The first step is catalyzed by hepatic 25-hydroxylase (CYP2R1, 11p15.2) and the second one is catalyzed by renal 1α-hydroxylase (CYP27B1, 12q13.1), which produces the active hormonal form of 1,25-(OH) D. Mutations of CYP2R1 have been associated with vitamin D-dependent rickets type 1B (VDDR1B), a very rare condition that has only been reported to affect 4 families to date. We describe 7 patients from 2 unrelated families who presented with homozygous loss-of-function mutations of CYP2R1. Heterozygous mutations were present in their normal parents. We identified a new c.124_138delinsCGG (p.Gly42_Leu46delinsArg) variation and the previously published c.296T>C (p.Leu99Pro) mutation. Functional in vitro studies confirmed loss-of-function enzymatic activity in both cases. We discuss the difficulties in establishing the correct diagnosis and the specific biochemical pattern, namely, very low 25-OH-D suggestive of classical vitamin D deficiency, in the face of normal/high concentrations of 1,25-(OH) D. Siblings exhibited the three stages of rickets based on biochemical and radiographic findings. Interestingly, adult patients were able to maintain normal mineral metabolism without vitamin D supplementation. One index case presented with a partial improvement with 1alfa-hydroxyvitamin D or alfacalcidol (1α-OH-D ) treatment, and we observed a dramatic increase in the 1,25-(OH) D serum concentration, which indicated the role of accessory 25-hydroxylase enzymes. Lastly, in patients who received calcifediol (25-OH-D ), we documented normal 24-hydroxylase activity (CYP24A1). For the first time, and according to the concept of personalized medicine, we demonstrate dramatic improvements in patients who were given 25-OH-D therapy (clinical symptoms, biochemical data, and bone densitometry). In conclusion, the current study further expands the CYP2R1 mutation spectrum. We note that VDDR1B could be easily mistaken for classical vitamin D deficiency. © 2017 American Society for Bone and Mineral Research.

摘要

维生素 D 需要两步羟化激活:第一步由肝 25-羟化酶(CYP2R1,11p15.2)催化,第二步由肾 1α-羟化酶(CYP27B1,12q13.1)催化,生成活性激素形式的 1,25-(OH) D。CYP2R1 的突变与维生素 D 依赖性佝偻病 1B(VDDR1B)有关,这是一种非常罕见的疾病,迄今为止仅报道了 4 个家族受其影响。我们描述了来自 2 个不相关家族的 7 名患者,他们均表现为 CYP2R1 纯合失活突变。其正常父母则携带杂合突变。我们发现了一种新的 c.124_138delinsCGG(p.Gly42_Leu46delinsArg)变异和先前报道的 c.296T>C(p.Leu99Pro)突变。体外功能研究证实了这两种情况均存在酶活性丧失。我们讨论了在面对正常/高浓度 1,25-(OH) D 时,正确诊断和特定生化模式(即提示经典维生素 D 缺乏的非常低的 25-OH-D)的困难。同胞们根据生化和影像学发现表现出佝偻病的三个阶段。有趣的是,成年患者无需维生素 D 补充即可维持正常的矿物质代谢。1 名指数病例在接受 1alfa-羟基维生素 D 或 alfacalcidol(1α-OH-D)治疗后出现部分改善,我们观察到血清 1,25-(OH) D 浓度显著升高,这表明辅助 25-羟化酶的作用。最后,在接受 calcifediol(25-OH-D)治疗的患者中,我们记录到正常的 24-羟化酶活性(CYP24A1)。根据个性化医疗的概念,我们首次证明了给予 25-OH-D 治疗的患者有显著改善(临床症状、生化数据和骨密度计)。总之,本研究进一步扩展了 CYP2R1 突变谱。我们注意到,VDDR1B 很容易被误诊为经典维生素 D 缺乏症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验